Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
To look for a needle in a haystack: the search for autoantibodies in multiple sclerosis.
Cobalamin as a regulator of serum and cerebrospinal fluid levels of normal prions.
Matrix metalloproteinase-2 and -9 as promising benefactors in development, plasticity and repair of the nervous system.
[Laquinimod is an oral drug with a marked neuroprotective effect for pathogenetic treatment of multiple sclerosis(review)].
Severe multiple sclerosis reactivation under fingolimod 3 months after natalizumab withdrawal.
Immunomodulatory activity of interferon-beta.
Observational Study Assessing Demographic, Economic and Clinical Factors Associated with Access and Utilization of Health Care Services of Patients with Multiple Sclerosis under Treatment with Interferon Beta-1b (EXTAVIA).
Effect of Boswellia papyrifera on cognitive impairment in multiple sclerosis.
Melatonin and endoplasmic reticulum stress: relation to autophagy and apoptosis.
Consensus Recommendations for the Diagnosis and Treatment of Multiple Sclerosis The Middle East North Africa Committee for Treatment and Research in Multiple Sclerosis (MENACTRIMS).
Building an RNA Sequencing Transcriptome of the Central Nervous System.
Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica.
miR-17-92 cluster targets Phosphatase and Tensin Homology and Ikaros Family Zinc Finger 4 to promote TH17-mediated inflammation.
[von Willebrand factor and adhesion molecules in patients with multiple sclerosis.]
HMG-CoA reductase inhibitors suppress maturation of human dendritic cells: new implications for atherosclerosis.
Bidirectional trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis.
Vm24, a Natural Immunosuppressant Peptide Potently and Selectively Blocks Kv1.3 Potassium Channels of Human T Cells.
Bevacizumab Diminishes Experimental Autoimmune Encephalomyelitis by Inhibiting Spinal Cord Angiogenesis and Reducing Peripheral T-Cell Responses.
Hematopoietic Stem Cell Therapy for Multiple Sclerosis: Top 10 Lessons Learned.
[Multimodal complex treatment in multiple sclerosis : Influence on motor performance and need of care.]
Antigen Microarrays for the Study of Autoimmune Diseases.
Consistency in Administration and Response for the Backward Push and Release Test: A Clinical Assessment of Postural Responses.
Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy.
Tremor in multiple sclerosis: The intriguing role of the cerebellum.
Method for the systematic reviews on occupational therapy and neurodegenerative diseases.
Pages
« first
‹ previous
…
254
255
256
257
258
259
260
261
262
…
next ›
last »